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INTRODUCTION: 
Diabetes mellitus is a metabolic disease charaterised by a high level of blood glucose. 
It can be classified in to insulin dependent diabetes mellitus (IDDM) and non-insulin 
dependent diabetes mellitus (NIDDM). Commonly the complications due to diabetes 
mellitus are best considered in three categories: macrovascular, microvascular and 
neuropathy. The systemic nature of diabetes mellitus justifies the search for its effects 
on the inner ear and the central auditory pathways. In diabetes, microangiopathic 
changes affecting the inner ear and the central nervous system are the most important 
fmdings, and have been reported by several authors (Jorgensen, 1961, Costa, 1967, 
Jorgensen and Buch,1961, Jorgensen, 1962, Kovar, 1973, Makishima et al., 1971, 
Wackym and Linthicum,1986, Zelenka and Kozak,1965). The association of hearing 
loss and diabetes mellitus was first reported by Jordao (1962). Other reported effects 
of diabetes mellitus on hearing includes; endolympahtic and perilymphatic 
haemorrhages (Kovar, 1973), cochlear hair cell loss, decrease of nerves of the spiral 
lamina and atrophy of the spiral ganglion in the cochlea and demyelinization and 
beading of the cochlear nerve (Makishima and Tanaka, 1971) and degenerative 
abnormalities of the nervous tissue of the brain stem, cerebellum and brain (Reske-
Nielsen eta/., 1965). 
There have been various conflicting reports regarding the incidence of hearing loss in 
diabetes mellitus which have been stated as varying from 0% (Borsuk et al., 1956; 
Kindler, 1955) to 93% (Derald, 1966). The typical hearing loss in diabetes mellitus is 
a pro~essive bilateral sensorineural type affecting primarily the higher frequencies; 
similar to that seen in presbyacusis (Colletti et al., 1985). Exceptions to this typical 
pattern have also been reported like low frequency hearing loss (Taylor and Irwin, 
1978) and unilateral hearing impairment with progressive or acute loss (Jorgensen, 
1962). 
Many authors state that there is no significant difference in pure tone audiometry 
between diabetic patients and control subjects (Colletti et al., 1985; Buller et al., 
1988; Donald et al., 1981; Filipa et al., 1985; Friedmann, 1975; Gibbin and Davis, 
1981; Goldsher et al., 1986; Hendriks eta/., 1985; Miller et a/., 1983; Osterhammel 
and Christau,1980; Parving et al., 1990; Sieger et a/., 1983; Taylor and lrwin,1978). 
Other studies, however have reported a significant hearing loss in diabetic subject 
when compared with normal control subjects (Kurien et al., 1989; Cullen and 
Cinnamond, 1993; Virtaniemi et al., 1994). Various factors like diabetic patients with 
poor control and with other complications have higher incidence of high frequency 
hearing loss when compared to well controlled and uncomplicated diabetics while the 
duration of diabetes having no effect on hearing loss (Cullen and Cinnamond, 1993; 
Virtaniemi et al., 1994). Some studies have reported correlation between diabetic 
retinopathies and hearing loss ( Kurien et al., 1989; Virtaniemi et al., 1994). 
Therefore, the aim of this study, done at Hospiptal Universiti Sains Malaysia, was; 
1) To compare pure tone hearing threshold in diabetic patients and non-diabetic 
subjects., and 
2) To study the impact of 
- duration of diabetes mellitus 
- metabolic control of diabetes mellitus and 
- association of presence of diabetic retinopathy on hearing thresholds for pure tones 
in diabetic patients. 
2 
MATERIALS AND METHODS: 
The present study was conducted at Hospital Universiti Sains Malaysia from 
December 1995 to January 1998. There are about 600 diabetic patients registered at 
diabetic clinic of this Hospital and clinical records of 542 of these diabetic patients 
were screened. All the patients with a history of ototoxic drug intake; head injury; 
family history of deafness; past history of meningitis mumps or typhoid fever; any 
neurological or other metabolic disease; blindness and renal insufficiency were 
excluded from the study. The patients who passed this screening were further 
interviewed to explore the above history. The diabetic patients who were fmally 
selected explained about the study and their written consent was taken. The 
particulars of the patient such as age, sex, body weight and body mass index, duration 
of the diabetes, type of diabetes, type of treatment and medication etc. were recorded. 
A detailed ENT examination was conducted and any patient with evidence of ear 
disease or other ENT diseases was excluded from the study. All patients were 
subjected to a full otological examination, including tuning fork testing using the 
Rinne and Weber tests (appendix- 1). 
Clinical examination was done to look for peripheral neuropathy and for the 
involvement of the autonomic nervous system. These patients. were asked to collect 
24 hour urine sample in a sterile bottle for the assessment of urinary albumin 
excretion rate. The urinary albumin above 30 microgram/ml was considered as 
evidence of diabetic nephropathy. The patients then called to the ENT clinic after over 
night fasting. Fasting blood samples were collected for biochemical tests; HbAl, 
serum lipids, fasting blood sugar etc. After that they were allowed to take their 
antidiabetic drugs and have breakfast. 
Pure tone threshold at octave of 250 Hz to 8000 Hz, both by air conduction and by 
bone conduction was determined. Narrow band masking was used where indicated. 
The equipment used comprised an Amplaid 450 audiometer (Italy). 
On the same day fundus examination was done by Ophthalmologist (after dilating the 
pupils with I% tropacamide eye drops in both eyes) to look for the evidence of 
retinopathy. The fundus findings were classified as no retinopathy, back ground 
retinopathy, pre-proliferative retinopathy and proliferative retinopathy. 
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The assessment of the diabetic control was done by the HbA 1 level during past few 
years and at the time of hearing assessment. The Eagle diagnostic, USA method was 
used for the quantitative determination of glycosylated haemoglobin in the blood. 
This method employs weakly binding cation exchange resin for rapid separation of 
. glyco-haemoglobin from non-glycosylated haemoglobin. The normal values are 6%-
8.3% in our population. The diabetic control was graded as 
Good control: HbA1levelless than 7.5%- 8.99%, 
Fair control: HbA1level of9%- 9.99% 
Poor control: HbA1level more than 10%. 
The controls were non-diabetic subjects with no family history of diabetes mellitus 
and modified glucose tolerance test was used to diagnose diabetes mellitus in this 
group, otherwise the same criteria were applied as for the diabetic patients. The 
controls were mostly from the ho~pital staff and were age and sex matched. Clinical 
methods and the audiometry examination was done in the same way as for the diabetic 
patients. 
Diabetic patients were 28 (Mean age 41.11 ± 11.53 with a range from 29-65 years) 
and 19 were non-diabetic controls (Mean age 37.42 ± 9.82 with a range from 28-64 
yaers). There was no statistically significant difference of ages between these two 
groups (p < 0.195). 
In the diabetic group mean duration of diabetes mellitus was 7.18 ± 3.62 years and 
mean HbA1 level was 9.88. The percentage of associated diabetic retinopaty in the 
patient group was 39.29%. The mean albumin excretion in diabetics was 0.778 
microgram/mi. 
The resulting data for pure tone thresholds were analysed using SPSS statistical 
programme. The Student's 't' test for independent variables was done. Correlation was 
calculated with Pearson correlation coefficients. 
RESULTS AND DISCUSSION: 
Adult onset diabetes mellitus has been recognised for centuries and is known to affect 
neural tissues and special sense organs and perhaps cause premature aging. A review 
of the audiological literature on hearing abnormalities in diabetics shows a divergence 
of results both for the prevalence of hearing loss from 0% (Borsuk et al., 1956, 
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Kindler, 1955, Gibbin and Davis, 1981, Harner, 1981, Colletti et al., 1985, Buller, et 
al., 1988,) to 93% (Derald, et al., 1966, Kurien et al., 1989, Cullen and Cinnamond, 
1993, Virtaniemi et al., 1994) and for the degree of hearing impairment. The 
divergence of the reported hearing changes in diabetics is hard to understand and may 
be due to several external variables rather than to the disease process it self; age of the 
patients, previous disease (ear diseases, acoustic trauma, ototoxicity, other associated 
metabolic diseases etc.) and methods of auditory evaluation etc. By using three 
different statistical methods,Taylor and Irwin (1978) obtained variable percentage of 
hearing losses from 13.2% to 94.7% in the same diabetic population. 
In order to reduce the interference of nonspecific variables, the pure tone thresholds 
assessment in the present study was done after the screening test for various factors 
which can cause hearing loss. Out of 542 diabetic cases only 28 cases were included 
in the present study who fulfilled the screening criteria. The excluded diabetics were 
either on drugs known to affect hearing or had other metabolic diseases which can 
affect hearing thresholds. The pure tone hearing thresholds result were compared with 
age and sex matched non-diabetic controls. 
Pure tone hearing thresholds in diabetic patients and controls: 
Pure tone hearing thresholds result for air and bone conduction are shown in table 1 
and 2. There was no significant difference at lower frequencies. The difference 
became statistically significant (p< 0.05 Wilcoxon W test) at high frequency (8000Hz) 
both for air and bone conductions. 
Table 1. Shows Pure tone air conduction hearing thresholds by frequencies (dB means, ± SD) 
in diabetics( n=28) and Non-diabetic control (n=19) groups. 
Pure tone Control subjects Diabetic patients 95% Confidence 't'-test 
frequency Mean and SD Mean and SD Interval of Mean (2-tailed) 
Lower Upper 
250Hz 27.23 (5.8) 26.87 (9.7) -5.40 4.68 0.886 
500Hz 25.39 (4.9) 26.03 _{_9.38) -4.09 5.37 0.787 
1000Hz 23.81 (4.19) 24.78 _(8.00) -3.07 5.00 0.631 
2000Hz 19.86 (5.68) 21.25 (7 .40) -2.67 5.43 0.496 
4000Hz 20.26 (7.94) 24.34 (12.46) -2.40 10.62 0.210 
8000Hz 23.28 (8.97) 35.98 (19.51) 3.02 22.35 0.001 * 
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* (Mann-Whitney test value = 0.020, significant p< 0.05) 
Table 2.Shows Pure tone bone conduction hearing thresholds by frequencies (dB means, ± SD) in 
diabetics (n= 28) and Non-diabetic control (n=19)groups. 
Pure tone Control subjects Diabetic patients 95% Confidence 
frequency Mean and SD Mean and SD Interval of Mean 
Lower Upper 
250Hz 14.86 (6.58) 15.89 (6.49) -2.88 4.93 
500Hz 17.63 ( 4.89) 20.44 (7.48) -1.12 6.74 
1000Hz 17.36 (5.80) 17.85 (7 .62) -3.67 4.65 
2000Hz 16.68 (5.48)_ 17.41 (8.23) -3.12 5.57 
4000Hz 19.86 (6.53) 24.19 (9.42) -0.69 9.35 
8000Hz 21.57 (7 .50) 29.81 (11.30) 2.24 14.22 
* (Mann-Whitney test value = 0.008, significant p< 0.05) 
This finding is in accordance with the findings of Cullen and Cinnamond, (1993), 
Kurien et al., (1989) and Virtaniemi et al., (1994). Similar high frequency hearing loss 
has been reported by various authors (Jannulis and Delijannis, 1936, Jorgensen and 
Buch, 1961, Axellson et al., 1978) and supports the hypothesis proposed by Snashall 
(1977) and by Gibbin and Davis (1981) that diabetes mellitus exacerbate the aging 
process. Further analysis was done to study the impact of various factore like duration 
of diabetes mellitus, metabolic control based on HbA1 level and association of 
retinopathy at this high frequency (8000Hz) pure tone hearing thresholds fmdings in 
diabetics. 
Duration of Diabetes and hearing loss: 
The diabetics were divided into two groups based on mean duration (7 years) of 
diabetes mellitus. The results are shown in table 3 
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't'-test 
(2-tailed) 
0.600 
0.157 
0.814 
0.573 
0.09 
0.008* 
Table 3. Association of the duration of diabetes with pure tone hearing thresholds at 
8000 Hz frequency is shown. The diabetic patients were divided into two groups on 
the basis of median duration of the diabetes mellitus. 
Duration of diabetes Duration of 
< 7 years. diabetes 
Pure tone frequency n=14 > 7 years. Mann-
Mean and SD n=14 Whitney 
Mean and SD Test 
8000Hz (Air conduction) 25.35± 13.54 46.60± 19.08 0.003* 
8000 Hz (Bone conduction) 24.82± 8.79 35.19± 11.52 0.020* 
significant p< 0.05 
Analysis of Pearson correlations was significant between the duration of diabetes 
mellitus and (mean air conduction and mean bone conduction) pure tone hearing 
thresholds. The duration of diabetes mellitus had significant effect on the hearing loss 
and had positive correlation at high frequency (8000Hz). This fmding supports the 
hypothesis of longer duration of diabetes mellitus giving rise to high frequency 
hearing loss on pure tone audiometry; a finding which is typical of presbyacusis 
(Arnst, 1985). 
Poor control of Diabetes mellitus and hearing loss: 
Poor control of diabetes mellitus was assessted by the HbA1 levels. The results are 
shown in table 4. 
Table 4. Shows the association of the metabolic control with pure tone hearing 
thresholds at 8000Hz frequency. The diabetic patients were divided in two groups; 
Poor control group having HbA1 level more than 10% and other group having HbA1 
of less than 10%. 
Pure tone frequency Poor control of Good/fair Mann-
diabetes mellitus control of Whitney 
n=11 diabetes Test 
Mean and SD mellitus n= 14 
Mean and SD 
8000 Hz(Air conduction) 39.31± 16.47 33.82± 21.45 0.306* 
8000 Hz (Bone conduction) 34.77± 10.15 26.40± 11.06 0.053* 
significant p< 0.05 
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Analysis of Pearson correlation was not significant between the poor control of 
diabetes mellitus and the (mean air conduction and mean bone conduction) pure tone 
hearing thresholds at higher frequencies (8000 Hz). Virtaniemi et al., (1994) also 
reported similar results in insulin-dependent diabetes mellitus patients while Kurien et 
al., (1989) reported positive correlation between poor control of diabetes and hearing 
threshold. Direct evidence to support poor control of diabetes mellitus and its effect 
on hearing remains to be proven. 
Presence of diabetic retinopathy and hearing loss: 
Analysis of presence or absence of diabetic retinopathy was studied and the results are 
shown in table 5. 
Table 5. Shows the association of diabetic retinopathies with pure tone hearing 
thresholds at 8000Hz frequency. 
Pure tone frequency Diabetes mellitus Diabetes mellitus Mann-
retinopathy retinopathy absent Whitney Test 
present n=17 
n=11 
8000 Hz (Air conduction) 44.31± 16.77 30.58± 19.69 0.038* 
8000 Hz (Bone conduction) 35.45± 9.98 25.93± 10.75 0.031 * 
significant p< 0.05 
Analysis of correlation between pure tone hearing loss at high frequency (8000Hz) 
and retinopathies was significant in our study. Similar correlationship was reported 
by Jorgensen and Buch (1961) and Virteniemi et al., (1994). This finding is an 
indirect evidence of microangiopathic changes in the hearing system (internal auditory 
artery, vasa nervosa of acoustic nerve, the vessels of modiolus, stria vascularis and 
spiral ligament) as reported by Costa (1967), Jorgensen and Buch (1961), Jorgensen 
(1962), Kovar (1973), Makishima et a/.,(1971), Zelenka and Kozak (1965). 
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CONCLUSIONS AND RECOMMENDATIONS: 
!.Diabetes mellitus causes pure tone hearing loss at high frequency (8000 Hz) 
compared to that of non-diabetic controls of the same age and sex. 
2. Duration of diabetes mellitus of more than 7 years was found to be one of the most 
important factor causing the hearing loss. 
3. Presence of associated retinopathy was also an important factor associated with the 
hearing loss. 
4. Poor control of diabetes as based on HbAl level was not a factor associated with 
the hearing loss. 
As all diabetic patients are at risk of suffering from hearing loss as well as retinopathy 
which has been an established fact for the past many years. It is recommended that all 
patients with diabetes mellitus should have hearing thresholds test done as a base line 
parameter to monitor the effect of the disease on hearing. 
The hearing tests should be done at regular intervals (six monthly) to detect the 
hearing loss early and advise them accordingly. In the Hospital University Sains 
Malaysia the equipment and the facilities for hearing tests are already available and 
can be done at nominal charges. This should be made use for the benefit of the 
patients who are on regular follow-up for diabetes mellitus. To achieve maximum 
benefits to the patients it is essential that all the doctors who are involved in the care 
of diabetic patients should be made aware of the possible complication of hearing loss 
and the diagnostic facilities available at Hospital University Sains Malaysia. 
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HEARING THRESHOLD ASSESSMENT IN DIABETIC 
PATIENTS AT HUSM 
GUIDELINES 
I. To screen all patients registered under diabetic clinic at hospital U.S.M ,below the age 
of 50 years and having known disease for more than three years • 
2. Exlusion criteria for the study are as follows ; 
(I) All patients With history of. excessive noise exposure. Example: Asking the 
patient about his/her working place and noise level at working place, etc. 
(ii) All patient with history of following ototoxic drugs usage: 
(a) Streptomycin 
(b) Gentamycin 
(c) Other amiuoglycosides (Vancomycin, Kanamycin, Tobromycin, 
Amikacin) 
(d) Ethacrynic acid 
(e) Ftusemide 
(f) Cytotoxic agents 
(g) Anticonvulsant drug - Phenytoin 
(h) Barbiturates 
(i) B- Blockers 
G) Antiheparinizing drugs 
(k) Dopamine agonist 
(1) Oral cantraceptive usage 
Example : History of streptomycin intake should be taken by asking the patient about any 
history of tuberculosis in the past treated with injections for I to 3 months period, 
similarly history of injection gentamycin intake or other .drugs usage by seeing patients 
previous treatment records. . . 
(iii) History ofHead Injury 
(iv) Family history of deafuess or ear abnormalities 
(v) Blindness 
(vi) Renal insufficiency- Serum creatnine > 120J.t ml/litre 
(vii) History of Meningitis 
(viii) History ofMumps 
(ix) History of Neurological diseases (including diabetic coma) 
(x) History of other endocrine and tnetabolic disorder 
,. 
., 
.. " J' 
., . .: i' 
3. Explain the patient about the study and get their consent in proper consent form. 
4. The patient will given ENT appointment with following instructions: 
-To come to ENT clinic at 8.30 am, with Gvemight fasting. 
- He/she has to collect and bring 24 hours urine sample in the sterile bottle which will 
be given to him/her. 
- The fasting blood sample for the analysis of various biochemical tests will be 
collected. 
- The ENT examination will be done in clinic. 
- The pure tone audiometry will be done on the same day. 
- 11te fundus examination will be done on the same day. 
5. The control group will be age and sex matched non diabetic healthy individuals with 
similar exlusion criterias as used for diabetic patients. The following will be the 
guidelines for thetn : 
- To get consent for the study. 
-To come to ENT clinic at 8.30 am with overnight fasting as they have to undergo 
modified glucose tolerance test. 
- Detailed ENT examination as in diabetic patients. 
- Detailed pure tone audiometry assessment. 
- Detailed fundus e~aminati«;)n. 
.~· 
..... i . 
~;,i..i: t ~- ~ 
Name 
Register Number 
Age 
Race 
Occupation 
Height 
Weight 
BMI 
Duration of DM 
Type IDDM 
HISTORY OF DRUG USAGE 
Streptomycin 
Gentamycin 
Other aminoglycosides 
(Vancomycin, Kanamycin, 
Tobromycin, Amikacin etc) 
Ethacrymic acid 
Frusemide 
Cytotoxic drugs 
Anticonvulsant 
Barbiturates 
B.Blockers 
Antiheparizing drugs 
Dopamine agonist 
Oral contraceptive 
Head injury 
Family history of deafness 
or ear abnormalities 
(I/C NO: 
NIDDM 
Yes No 
,. J 
[ 
J 
1 
Blindness 
Renal insufficiency 
-Serum creatnine>l20~ml/litre 
History of meningitis 
History of mumps 
History of neurological 
diseases 
History of other metabolic 
disorder 
TREATMENT INSULIN 
Oral hypoglycemic agents 
Dibenclamide 
Glibenclamide 
Gliclazide 
Glipizide 
Metforrnin 
Combination 
OTHER SYSTEMIC CONDITIONS 
Hypertension 
Ischemic heart dis~~ses 
Nephropathy 
Neuropathy 
Hyperlipidemia 
OTHER MEDICINE SPECIFIED 
Yes No 
. .__I _ ____. 
:------------------------------
:------------------------------
:------------------------------
:------------------------------
2 
.~ I .~ .. J 
l"!~'t ... ' 
• 
INVESTIGATION 
Blood urea nitrogen 
Serum creatnine 
Calcium 
Phosphate 
TG 
HDL 
LDL 
C.peptide 
HBAI 
FBS 
24 hour urine protein 
:------------------------------
:------------------------------
:------------------------------
J 
:------------------------------
:------------------------------
:------------------------------
:----------------------------~-
PREVIOUS HBA 
·Level during last ?ew year 
1991 1992 
DATE HBAI LEVEL. DATE HBAI LEVEL 
1993 1994 
DATE HBAr LEVEL DATE HBAr LEVEL 
1995 1996 
DATE HBAI LEVEL DATE HBAI LEVEL 
3 
ENT EXAMINATION 
EAR Right Left 
External 
1. Nortnal 
2. Abnormal 
State nature of abnormality-----------------------------
Wax 
1. Absent 
2. Present but ·not impacted 
3. Impacted 
Ear discharge 
1. Present scanty 
2. Present profuse 
3. Absent 
·- .. 
Tympanic membrane 
1. ·Normal 
2. Perforation 
3. Abnormal without perforation 
Mobility of tympanic 
membrane 
1. Mobile 
2. Restricted 
3. Non mobile 
Tuning fork test 
Rinnes test 
1. Positive 
2. Reduced positive 
3. Equal 
4. Negative 
5. False negative 
Weber· test 
1. Not heard 
2. Normal 
3. Right lateralized 
4. Left lateralized 
Absolute bone conduction 
test 
1. Normal 
2. Reduced 
Any other ear finding 
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THROAT 
Oral hygine 
1. Good 
2. Bad 
Tonsils 
1·. Normal 
2. Congested 
3. Enlarged 
4. Follicles 
5. Cheesy material comes on pressure 
·Pharynx 
1. Normal 
2. Acute inflammation 
3. Chronic inflammation 
Post Nasal Examination 
1. Normal 
2. Post nasal drip 
3. Adenoid hypertrophy 
4. Adenoid hypertrophy with post nasal drip 
5. Not possible 
Any other throat problems 
NOSE 
Anterior rhinoscopy 
Right/Left/Both 
1. Normal 
2. Abnormal 
Septum 
1. Normal 
2. Deviated 
3. ·Spur 
4. Spur with deviated 
Secretions 
Right/Left/Both 
1. Absent 
2. Watery 
3. Mucoid 
4. Purulent 
5. Mucopurulent 
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Inferior terbinate 
Right/Left/Both . 
1. Normal 
2. Congested 
3. Allergic hypertropy 
Any other nasal findings 
Cervical glands 
1. Palpable non tender 
2. Tender · 
3. Non - palpable 
Ophthalmic examination of fundus· 
1. No retinopathy. . . 
2. Background diabetic· 
retinopathy. .. · ·· 
3. Pre-proliferative 
diabetic retinopathy. 
4. Proliferative 
retinopathy 
(end-stage diabetic eye disease) 
Pure tone audiometry result 
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